drugset / Trial / NCT01845025
Study of Safety of Foradil in Patients With Persistent Asthma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study was to assess whether the risk of serious asthma-related events (asthma-related hospitalizations, asthma related intubations, and asthma related deaths) in adolescents and adults (12 years of age and older) taking inhaled formoterol fumarate/fluticasone propionate combination was the same as those taking inhaled fluticasone propionate alone.
Timeline
- Start
- 2013-05
- Primary completion
- 2016-05
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 100 ug | Inhaled |
| Subject | Fluticasone propionate | Other / unclassified | 250 ug | Inhaled |
| Subject | Fluticasone propionate | Other / unclassified | 500 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 12 ug | Inhaled |